廣告

2020年5月3日 星期日

Roche Coronavirus Antibody Test Wins FDA Approval for Emergency UseRoche Holding AG test can assess over 4,000 patients a day. 韓國 SEEGENE公司2~3周開發測試工具 created coronavirus test kits in three weeks (由AI 認出三基因,約4小時知道)

5.3スイス製薬大手Roche(ロシュ)の新型コロナウイルス抗体検査薬が、アメリカの食品医薬品局(FDA)から緊急使用の許可を得ました。日本でも5月中に承認申請する方針です。



Swiss health-care giant Roche says its test has proven 100% accurate at detecting Covid-19 antibodies in the blood, and 99.8% accurate at ruling out the presence of those antibodies.


3.13
A new highly-automated test can assess over 4,000 patients a day, a 10-fold increase from existing technologies.
Roche Holding AG said it won emergency approval from the U.S. government for a highly automated coronavirus test, potentially speeding up the ability to test patients by a factor of 10.
The U.S. Food and Drug Administration granted “Emergency Use Authorization” to the test, which runs on Roche’s cobas 6800/8800 systems. The tool also is available in Europe and countries that accept its CE marking for medical devices, Roche said.
The 8800 version is capable of testing 4,128 patients a day, and the 6800 can test as many as 1,440, the Basel, Switzerland-based company said.
“We are increasing the speed definitely by a factor of 10,” Thomas Schinecker, head of Roche’s diagnostics unit, said in an interview.
---
"Even if nobody is asking us to, we are a molecular diagnosis company. We have to prepare in advance."

Before there were any cases of novel coronavirus confirmed in South Korea, one of the country's biotech firms had begun preparing to make testing kits to identify the disease.

Before there were any cases of novel coronavirus confirmed in South Korea, one of the country's biotech firms had begun preparing to make testing kits to identify the disease.

CNN.COM

How this South Korean company created coronavirus test kits in three weeks




韓國SEEGENE公司2~3周開發測試工具 (由AI 認出三基因,約4小時知道結果)

SEEGENE
会社
株価: 096530 (KOSDAQ) ₩54,400 -4,600.00 (-7.80%)
3月12日 午後3:20 GMT+9 - 免責事項
設立: 2000年

沒有留言:

網誌存檔